By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


American Association for Cancer Research 

615 Chestnut St.
17th Floor
Philadelphia  Pennsylvania  19106-3483  U.S.A.
Phone: 215-440-9300 Fax: 215-440-9313


Company News
Provectus Reports Data On PV-10 In Combination Therapy And T Cell Mediated Immunity Presented At AACR Annual Meeting 2016 4/22/2016 9:14:11 AM
Affimed (AFMD) Presents Data On EGFRwt and EGFRvIII-Targeting NK- And T-Cell Tandabs At The AACR Annual Meeting 2016 4/21/2016 8:31:50 AM
Affimed (AFMD) Presents Data On AFM13-Mediated Innate/Adaptive Immune Crosstalk At The AACR Annual Meeting 2016 4/21/2016 8:28:45 AM
Merrimack (MACK) Unveils Its Latest Antibody Directed Nanotherapeutic, MM-310, At The 2016 AACR Annual Meeting 4/21/2016 6:30:05 AM
Juno (JUNO), Five Prime (FPRX) are Quiet Winners at AACR 4/21/2016 6:16:52 AM
Peregrine (PPHM) Release: Preclinical Data Presented At AACR Annual Meeting Demonstrate Enhanced Therapeutic Benefit Of Combining A Ps-Targeting Antibody With Anti-Pd-1 Therapy In Models Of Triple Negative Breast Cancer (TNBC) 4/20/2016 3:15:37 PM
AACR 2016 Research Shows Circulogene Theranostics Liquid Biopsy Excels At Real-Time Monitoring Of Cancer Mutations 4/20/2016 11:47:19 AM
Xcovery Presents Data Supporting The Potential Efficacy Of X-396 In Patients With ALK+ Non-Small Cell Lung Cancer At The AACR Annual Meeting 2016 4/20/2016 11:43:42 AM
Acetylon Pharmaceuticals Announces The Presentation Of Preclinical Data At AACR Supporting The Use Of Selective HDAC6 Inhibition To Modulate Chronic Lymphocytic Leukemia (CLL) Immunobiology 4/20/2016 11:32:03 AM
Merck & Co. (MRK) Statement On Blueprint Project Findings Presented At The AACR 2016 Annual Meeting 4/20/2016 10:12:55 AM